AstraZeneca progresses Ambition Zero Carbon programme with Honeywell partnership to develop next-generation respiratory inhalers
New inhalers would have near-zero Global Warming Potential propellant.AstraZeneca also announces all imported electricity coming from renewable sources and sets new supplier targets.AstraZeneca and Honeywell will partner to develop next-generation respiratory inhalers using the propellant HFO-1234ze, which has up to 99.9% less Global Warming Potential (GWP) than propellants currently used in respiratory medicines.[1] Today’s announcement coincides with the publication of the Company’s annual Sustainability Report